GlassScriptPhysician profile
Sergio Manimbo
NPI 1336276278
$574.26
in general payments reported to CMS, 2019-2025
10 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.23 · 2021: $76.53 · 2022: $83.01 · 2023: $62.50 · 2024: $166 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $176.63 | 2023-2025 | Stelara, Simponi Aria, Simponi |
| Takeda Pharmaceuticals U.S.A., INC. | $87.64 | 2024-2025 | Entyvio |
| Redhill Biopharma INC. | $73.97 | 2021-2022 | |
| Abbvie INC. | $59.80 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.18 | 2022-2024 | Xifaxan |
| Nestle Healthcare Nutrition INC. | $40.78 | 2020-2021 | |
| Genzyme Corporation | $23.88 | 2025 | |
| Ardelyx, INC. | $23.24 | 2024 | Ibsrela |
| Exact Sciences Corporation | $20.37 | 2023 | Cologuard Collection Kit |
| Ironwood Pharmaceuticals, INC | $17.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergio Manimbo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.